ResearcherJinan UniversityActive in the last 2 years
Mohammed Alnaggar
Matched on ORCID iD 0000-0002-3768-7083; OpenAlex author ID A5060272154. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Synergistic Effect of Fecal Microbiota Transplantation, γδT Cell Immunotherapy, and Pembrolizumab in Refractory Advanced Pancreatic Cancer: A Case Report. Co-author DOI 10.1007/s12029-025-01368-9↗
- Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients. Co-author DOI 10.1038/s41392-020-00260-1↗
- Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer. First author DOI 10.1007/s12026-017-8959-2↗
- Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer. First author DOI 10.1159/000490874↗
- An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer. First author DOI 10.18632/oncotarget.21974↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mao Lin · 4 shared papers, 2017–2020 · strength 0.36
- Paper Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic ca… DOI 10.1038/s41392-020-00260-1↗
- Paper Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic can… DOI 10.1007/s12026-017-8959-2↗
- Paper Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer. DOI 10.1159/000490874↗
- Jibing Chen · 4 shared papers, 2017–2020 · strength 0.36
- Paper Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic ca… DOI 10.1038/s41392-020-00260-1↗
- Paper Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic can… DOI 10.1007/s12026-017-8959-2↗
- Paper Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer. DOI 10.1159/000490874↗
- Lizhi Niu · 4 shared papers, 2017–2020 · strength 0.36
- Paper Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic ca… DOI 10.1038/s41392-020-00260-1↗
- Paper Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic can… DOI 10.1007/s12026-017-8959-2↗
- Paper Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer. DOI 10.1159/000490874↗
- Li Gong · 1 shared paper, 2026 · strength 0.32
- Kecheng Xu · 3 shared papers, 2017–2018 · strength 0.25
- Paper Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic can… DOI 10.1007/s12026-017-8959-2↗
- Paper Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer. DOI 10.1159/000490874↗
- Paper An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy … DOI 10.18632/oncotarget.21974↗
- Xiaoyan Zhang · 1 shared paper, 2020 · strength 0.11
- Yong Jiang · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.